Trial Profile
Phase III trial of strontium ranelate (Protelos) compared with alendronic acid in postmenopausal women, assessed using bone biopsies.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Mar 2011
Price :
$35
*
At a glance
- Drugs Strontium ranelate (Primary) ; Alendronic acid
- Indications Fracture; Postmenopausal osteoporosis
- Focus Therapeutic Use
- 25 Mar 2011 New trial record